RNAZ
NASDAQ · Biotechnology
Transcode Therapeutics Inc
$1.71
+0.02 (+1.18%)
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+1,059.1% upside
Low Target
$14.35
Average Target
$19.82
High Target
$27.60
Current Price
$1.71
Current
$1.71
$1.71
Target
$19.82
$19.82
$14.35
$19.82 avg
$27.60
Scenario Analysis
Bear Case
$14.35
739.2%
Low target
Base Case
$19.82
+1,059.1%
Avg target
Bull Case
$27.60
+1,514.0%
High target
Risk/Reward
2.0x
Favorable
Price in Context
52-Week High
$20.99
-91.9% from high
52-Week Low
$1.58
+8.3% from low
Target vs 52W High
$19.82
-5.6% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 39 | 82% | $257.58 | -3.3% |
| AMGN | Hold | 43 | 47% | $190.87 | -54.4% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +138.3% |
| VRTX | Strong Buy | 36 | 81% | $438.34 | -16.9% |
| REGN | Buy | 38 | 68% | $76.80 | -89.8% |
| MRNA | Hold | 30 | 37% | $149.45 | -24.2% |
| NTRA | Strong Buy | 30 | 87% | $142.91 | -65.3% |
| RVMD | Strong Buy | 28 | 93% | $114.11 | -43.4% |